Encouraging discoveries

MS finding supports T-cell targeting
By Karen Bernstein
Editor-in-Chief

The discovery of the dominant immune response that causes multiple sclerosis, announced last week by researchers at Neurocrine Biosciences Inc. and Stanford University, is validating an approach taken by several biotech companies.